TOCQUEVILLE ASSET MANAGEMENT L.P. - STEMLINE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$402,000
+9.8%
45,500
+46.3%
0.01%
+25.0%
Q2 2015$366,000
-25.6%
31,100
-8.5%
0.00%
-33.3%
Q1 2015$492,000
+51.9%
34,000
+78.9%
0.01%
+100.0%
Q4 2014$324,000
+15.7%
19,000
-15.6%
0.00%0.0%
Q3 2014$280,000
-33.0%
22,500
-21.1%
0.00%
-25.0%
Q2 2014$418,000
-30.4%
28,500
-3.4%
0.00%
-50.0%
Q1 2014$601,000
+70.3%
29,500
+63.9%
0.01%
+60.0%
Q4 2013$353,000
-35.1%
18,000
+50.0%
0.01%
-28.6%
Q3 2013$544,000
+25.3%
12,000
-34.1%
0.01%
+16.7%
Q2 2013$434,00018,2000.01%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 475,200$6,877,0003.03%
Avoro Capital Advisors LLC 475,000$6,873,0002.64%
VHCP Management, LLC 451,400$6,532,0001.50%
Sio Capital Management, LLC 140,000$2,026,0001.15%
Opus Point Partners Management, LLC 75,000$1,085,0000.91%
Eventide Asset Management 620,200$8,974,0000.68%
Telemetry Investments, L.L.C. 55,000$796,0000.44%
Healthcare Value Capital, LLC 25,000$362,0000.40%
TFS CAPITAL LLC 259,916$3,761,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 672,562$9,732,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders